Showing results (361-370 of 443) with videos related to

Sort By:
Pageof 45
The Journal of Allergy and Clinical Immunology|July 21, 2010
Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndromeLauri M Burroughs, Troy R Torgerson, Rainer Storb, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donorsTerry Furlong, Hans-Peter Kiem, Frederick R Appelbaum, et al.
Blood Advances|October 14, 2021
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphomaVictor A Chow, Ryan D Cassaday, Theodore A Gooley, et al.
Blood|September 30, 2009
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndromeJohn M Pagel, Theodore A Gooley, Joseph Rajendran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patientsScott S Tykodi, Nobuharu Fujii, Nathalie Vigneron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term SurvivorsJohnnie J Orozco, Phuong T Vo, Ted A Gooley, et al.
British Journal of Haematology|May 20, 2003
Recombinant human macrophage colony-stimulating factor-induced thrombocytopenia in dogsKraig Abrams, Murad Y Yunusov, Sherrill Slichter, et al.
Transplantation|April 17, 2003
FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host diseaseMurad Y Yunusov, George E Georges, Rainer Storb, et al.
Arthritis and Rheumatism|May 30, 2006
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosisRichard A Nash, Peter A McSweeney, J Lee Nelson, et al.
Haematologica|June 6, 2020
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decadesJason P Cooper, Barry E Storer, Noa Granot, et al.
Pageof 45